• Users Online: 74812
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER – survey)
Ashish Sharma,Frank G Holz,Carl D Regillo,K Bailey Freund,David Sarraf,Arshad M. Khanani,Caroline Baumal,Nancy Holekamp,Ramin Tadayoni,Nilesh Kumar,Nikulaa Parachuri,Baruch D Kuppermann,Francesco Bandello,Giuseppe Querques,Anat Loewenstein,Sengül Özdek,Kourous Rezai,Kodjikian Laurent,Alper Bilgic,Paolo Lanzetta,Dinah Zur,Nicolas Yannuzzi,Giulia Corradetti,Peter Kaiser,Assaf Hilely,David Boyer,Aleksandra Rachitskaya,Usha Chakravarthy,Maximilian Wintergerst,Valentina Sarao,Barbara Parolini,Prithvi Mruthyunjaya,Quan Dong Nguyen,Diana DO,Pearse A Keane,Tarek Hassan,Jayanth Sridhar,David Eichenbaum,Dilraj Grewal,Martin Splitzer
Expert Opinion on Biological Therapy.2023;23(8)851
[DOI]
2Efficacy of an Indian Bevacizumab BIOSimilar (BEVATAS) for Type 1 and Aggressive Posterior Retinopathy of Prematurity (BIOS-ROP Study)
Somnath Chakraborty,Jay Sheth
Clinical Ophthalmology.2024;Volume 18(8)61
[DOI]
3Safety and efficacy of ranibizumab biosimilar (Razumab®) as a cost-effective alternative to the innovator molecule for macular disorders in real-world
Sonal Paliwal,Riddhima Deshpande,Prerna Upadhyay
Indian Journal of Clinical and Experimental Ophthalmology.2023;9(3)329
[DOI]
4Ranibizumab Biosimilars for Neovascular Age-related Macular Degeneration, Macular Oedema with Retinal Vein Occlusion and Myopic Choroidal Neovascularization
Sruthi Arepalli
US Ophthalmic Review.2022;16(2)80
[DOI]
5Anti-vascular endothelial growth factor biosimilars for macular degeneration
Tomiko Sunaga,Masayuki Maeda,Takeshi Hasegawa,Andrew N Mason,Hisashi Noma,Erika Ota
Cochrane Database of Systematic Reviews.2023;2023(8)80
[DOI]
6Retina: a unique subspecialty in the biosimilar landscape
Ashish Sharma,Nilesh Kumar,Nikulaa Parachuri,Carl D. Regillo,Francesco Bandello,Baruch D. Kuppermann
Eye.2022;36(6)1145
[DOI]
7The Future of Biosimilars and Biobetters in Ophthalmology
Ashish Sharma,Baruch D Kuppermann,Anat Loewenstein
US Ophthalmic Review.2022;16(1)6
[DOI]
8Real-world evidence in the use of Bevacizumab in age-related macular degeneration (ArMD): a scoping review
Ainhoa Gomez-Lumbreras,Priyanka Ghule,Rupesh Panchal,Theodoros Giannouchos,Catherine M. Lockhart,Diana Brixner
International Ophthalmology.2023;43(12)4527
[DOI]
9Biosimilars for Retinal Diseases: A Review of the Literature
Rachel N. Israilevich,Kannan Sharma,Matthew R. Starr
International Ophthalmology Clinics.2024;64(1)129
[DOI]
10Efficacy, Safety and Immunogenicity of Sun’s Ranibizumab Biosimilar in Neovascular Age-Related Macular Degeneration: A Phase 3, Double-Blind Comparative Study
Asim K. Ghosh,Usha S. Nikumbh,Chaitanya K. Shukla,Rohit S. Laul,Abhishek Dixit,Santosh K. Mahapatra,Sameera Nayak,Urmil M. Shah,Sandeep Parwal,Narendran Venkatapathy,Natasha Radhakrishnan,Anup Kelgaonkar,Sandeep Saxena,Divyansh Mishra,Vivek Pravin Dave,Perwez Khan,Manojkumar R. Saswade,Malli S. Shantilal,Kim Ramasamy,Smitha Sreekanta,Mandodari Rajurkar,Maulik Doshi,Sapan Behera,Piyush Patel,Shilpi Dhawan,Lalit Lakhwani
Ophthalmology and Therapy.2024;64(1)129
[DOI]
11Treatment Landscape of Macular Disorders in Indian Patients with the Advent of Razumab™ (World’s First Biosimilar Ranibizumab): A Comprehensive Review
Shashikant Sharma,Tanishq Sharma,Somdutt Prasad,Mahesh Gopalakrishnan,Alok Chaturvedi
Ophthalmology and Therapy.2021;10(3)431
[DOI]
12Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World Evidence
Debdulal Chakraborty,Soumen Mondal,Subhendu Boral,Arnab Das,Tushar Kanti Sinha,Saptorshi Majumdar,Ranabir Bhattacharya,Ritobroto Maitra
Clinical Ophthalmology.2023;Volume 17(3)1067
[DOI]
13Efficacy and safety of a new ranibizumab biosimilar CKD-701 using a pro re nata treatment regimen in neovascular age-related macular degeneration: A phase 3 randomized clinical trial
Chang Ki Yoon,Jaeryung Oh,Kunho Bae,Un Chul Park,Kyung-Sang Yu,Hyeong Gon Yu,Demetrios G. Vavvas
PLOS ONE.2022;17(11)e0275611
[DOI]
14Biosimilars for the Treatment of Retinal Diseases
Raja Narayanan,Seenu M. Hariprasad,Jay Sheth
Ophthalmic Surgery, Lasers and Imaging Retina.2021;52(5)242
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal